The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Major Grant Funding for Collaborative RA Projects

Major Grant Funding for Collaborative RA Projects

February 1, 2010 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In the last three years, the ACR REF has raised more than $26 million toward the $30-million goal for the Within Our Reach: Finding a Cure for Rheumatoid Arthritis (RA) campaign. Even in the worst economy this country has seen since the Great Depression, in fiscal year 2009, contributions to the Within Our Reach campaign exceeded $6.1 million. For the first quarter of fiscal year 2010, more than $1.1 million has already been received.

You Might Also Like
  • Rethink Rheumatoid Arthritis Research
  • Without You, ACR REF Wouldn’t Be Here
  • Closer to a Cure
Explore This Issue
February 2010
Also By This Author
  • Coding Corner Answer

“We are committed to strengthening the national research environment in RA and other inflammatory diseases and have invested $18 million into research to find a cure for RA,” says E. William St.Clair, MD, REF president. “Research into the etiology, pathogenesis, and treatment—as well as healthcare systems’ effects on RA—are high-priority goals that will positively affect the lives of patients with this disease and their family members.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Mentor the Next Generation

Applications for the REF Preceptorship program are available online now at www.rheumatology.org/REF.

Over the next two years, through the Within Our Reach RA grant program, the REF will expand beyond basic research and commit $12 million in research funding to more collaborative projects, which will focus on translating recent advances in the prevention and treatment of RA into clinical practice for individuals and communities at risk.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

December 2009 first marked the deadline for applications for the fourth round of research grants. Nearly 40 applications were received and are under review by a panel of RA research experts. The fourth round of grant recipients is expected to be announced in June 2010, and funding will begin in July.

Visit the Within Our Reach Web site at www.WithinOurReach.info to read about current Within Our Reach–funded projects.

Filed Under: Conditions, From the College, Professional Topics, Rheumatoid Arthritis Tagged With: Basic research, Clinical research, REF News, Rheumatoid arthritisIssue: February 2010

You Might Also Like:
  • Rethink Rheumatoid Arthritis Research
  • Without You, ACR REF Wouldn’t Be Here
  • Closer to a Cure
  • ‘Within Our Reach’ Gears Up for Second Round of RA Grants

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)